Viewing Study NCT02873650


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-22 @ 7:44 AM
Study NCT ID: NCT02873650
Status: TERMINATED
Last Update Posted: 2020-12-08
First Post: 2016-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatic Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatic impairment View
None Healthy volunteers View
None Clinical pharmacology study View
None DRB436 View
None dabrafenib View
None normal hepatic function View
None impaired hepatic function View